Total Payments
$178,082
2024 Payments
$45,866
Companies
34
Transactions
1,167
Medicare Patients
737
Medicare Billing
$173,681
Payment Breakdown by Category
Other$126,531 (71.1%)
Food & Beverage$35,680 (20.0%)
Travel$8,098 (4.5%)
Consulting$7,633 (4.3%)
Education$140.33 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $126,531 | 68 | 71.1% |
| Food and Beverage | $35,680 | 1,041 | 20.0% |
| Travel and Lodging | $8,098 | 42 | 4.5% |
| Consulting Fee | $7,633 | 3 | 4.3% |
| Education | $140.33 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $57,887 | 149 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $40,556 | 120 | $0 (2024) |
| Allergan, Inc. | $23,696 | 99 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $16,118 | 112 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $10,672 | 28 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $7,766 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $5,301 | 165 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $4,943 | 107 | $0 (2024) |
| Alkermes, Inc. | $3,972 | 128 | $0 (2024) |
| ITI, Inc. | $1,989 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,866 | 167 | Janssen Pharmaceuticals, Inc ($25,622) |
| 2023 | $23,253 | 121 | Teva Pharmaceuticals USA, Inc. ($15,730) |
| 2022 | $32,442 | 152 | Janssen Pharmaceuticals, Inc ($16,407) |
| 2021 | $15,557 | 170 | Janssen Pharmaceuticals, Inc ($7,970) |
| 2020 | $6,564 | 150 | Sunovion Pharmaceuticals Inc. ($3,496) |
| 2019 | $13,453 | 131 | Avanir Pharmaceuticals, Inc. ($9,528) |
| 2018 | $18,932 | 147 | Allergan Inc. ($9,648) |
| 2017 | $22,015 | 129 | Allergan Inc. ($13,466) |
All Payment Transactions
1,167 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $218.21 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $131.22 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $86.99 | General |
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $38.51 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $145.88 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Neurology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $6.01 | General |
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: CNS | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $38.10 | General |
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| 11/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Neuropsychiatry | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,440.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 207 | 562 | $71,310 | $48,642 |
| 2022 | 7 | 223 | 693 | $100,853 | $54,889 |
| 2021 | 4 | 165 | 712 | $52,834 | $37,150 |
| 2020 | 2 | 142 | 728 | $46,482 | $33,000 |
Total Patients
737
Total Services
2,695
Medicare Billing
$173,681
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 171 | $26,114 | $18,859 | 72.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 38 | 169 | $12,954 | $9,801 | 75.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 51 | 79 | $9,771 | $7,660 | 78.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 25 | 79 | $12,094 | $6,207 | 51.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 26 | 27 | $4,631 | $3,287 | 71.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 20 | $2,474 | $1,939 | 78.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 17 | 17 | $3,273 | $888.68 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 141 | $21,971 | $15,532 | 70.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 32 | 170 | $26,649 | $15,245 | 57.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 54 | 272 | $20,068 | $14,789 | 73.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 45 | 54 | $14,379 | $3,999 | 27.8% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 25 | 26 | $9,736 | $2,725 | 28.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 19 | 19 | $5,802 | $1,878 | 32.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 11 | 11 | $2,247 | $720.63 | 32.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 67 | 354 | $26,118 | $18,462 | 70.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 67 | 324 | $21,399 | $14,434 | 67.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 19 | 21 | $3,292 | $2,634 | 80.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 13 | $2,026 | $1,621 | 80.0% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 71 | 364 | $26,935 | $18,886 | 70.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 71 | 364 | $19,547 | $14,114 | 72.2% |
About Louis Belzie, MD, PHD
Louis Belzie, MD, PHD is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861438681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Louis Belzie, MD, PHD has received a total of $178,082 in payments from pharmaceutical and medical device companies, with $45,866 received in 2024. These payments were reported across 1,167 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($126,531).
As a Medicare-enrolled provider, Belzie has provided services to 737 Medicare beneficiaries, totaling 2,695 services with total Medicare billing of $173,681. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Brooklyn, NY
- Active Since 06/21/2006
- Last Updated 09/21/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861438681
Products in Payments
- INVEGA SUSTENNA (Drug) $56,271
- AUSTEDO (Drug) $25,861
- VRAYLAR (Drug) $25,182
- LATUDA (Drug) $15,943
- Austedo XR (Drug) $14,260
- NUEDEXTA (Drug) $10,749
- INGREZZA (Drug) $4,905
- ABILIFY MAINTENA (Drug) $2,695
- REXULTI (Drug) $2,671
- CAPLYTA (Drug) $2,038
- ARISTADA (Drug) $1,868
- Aristada 441 mg (Drug) $1,142
- HETLIOZ (Drug) $960.35
- LYBALVI (Drug) $623.47
- INVEGA TRINZA (Drug) $533.25
- ABILIFY MYCITE (Drug) $431.63
- UZEDY (Drug) $334.35
- PERSERIS (Drug) $272.24
- VIVITROL (Drug) $230.76
- ABILIFY ASIMTUFII (Drug) $228.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Mark Owens, Do, DO
Psychiatry — Payments: $502,442
Psychiatry $502,442
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Alexander Pinkusovich, Md, MD
Psychiatry — Payments: $111,246
Psychiatry $111,246
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833
Dr. Irina Kiblitsky, M.d, M.D
Psychiatry — Payments: $22,079
Psychiatry $22,079